Advertisement
Screener

Acorda Therapeutics, Inc. Operating Cash Flow

Acorda Therapeutics, Inc. Operating Cash Flow

Acorda Therapeutics, Inc. reported Operating Cash Flow of -$20.18 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-14.

Discontinued › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2024-05-14

  • Acorda Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2024-03-31 was -$20.18M.
  • Acorda Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2023-12-31 was -$3.02M, a 133.29% decline year-over-year.
  • Acorda Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2023-09-30 was $7.61M.
  • Acorda Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2023-06-30 was -$11.56M.
  • Acorda Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$13.98M.
  • Acorda Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$20.92M.
  • Acorda Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2021 was -$41.35M.
  • Acorda Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2020 was -$61.01M.
Period endNet Cash Provided by (Used in) Operating Activities 3 monthNet Cash Provided by (Used in) Operating Activities 6 monthNet Cash Provided by (Used in) Operating Activities 6 month as first filedNet Cash Provided by (Used in) Operating Activities 9 monthNet Cash Provided by (Used in) Operating Activities 9 month as first filedNet Cash Provided by (Used in) Operating Activities 12 monthNet Cash Provided by (Used in) Operating Activities 12 month as first filed
2024-03-31-$20.18M
10-Q · filed 2024-05-14
-$23.20M
derived: sum of 2 quarters · filed 2024-05-14
-$15.60M
derived: sum of 3 quarters · filed 2024-05-14
-$27.15M
derived: sum of 4 quarters · filed 2024-05-14
2023-12-31-$3.02M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01
$4.59M
derived: sum of 2 quarters · filed 2024-04-01
-$6.97M
derived: sum of 3 quarters · filed 2024-04-01
-$13.98M
10-K · filed 2024-04-01
2023-09-30$7.61M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14
-$3.95M
derived: sum of 2 quarters · filed 2023-11-14
-$10.97M
10-Q · filed 2023-11-14
-$1.90M
derived: sum of 4 quarters · filed 2024-05-14
2023-06-30-$11.56M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
-$18.57M
10-Q · filed 2023-08-09
-$9.51M
derived: sum of 3 quarters · filed 2024-05-14
-$11.35M
derived: sum of 4 quarters · filed 2024-05-14
2023-03-31-$7.02M
10-Q · filed 2024-05-14
$2.05M
derived: sum of 2 quarters · filed 2024-05-14
$209.00K
derived: sum of 3 quarters · filed 2024-05-14
-$14.30M
derived: sum of 4 quarters · filed 2024-05-14
2022-12-31$9.07M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01
$7.23M
derived: sum of 2 quarters · filed 2024-04-01
-$7.29M
derived: sum of 3 quarters · filed 2024-04-01
-$20.92M
10-K · filed 2024-04-01
2022-09-30-$1.84M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14
-$16.35M
derived: sum of 2 quarters · filed 2023-11-14
-$29.99M
10-Q · filed 2023-11-14
-$26.75M
derived: sum of 4 quarters · filed 2023-11-14
2022-06-30-$14.51M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
-$28.15M
10-Q · filed 2023-08-09
-$24.91M
derived: sum of 3 quarters · filed 2023-08-09
-$33.92M
derived: sum of 4 quarters · filed 2023-08-09
2022-03-31-$13.64M
10-Q · filed 2023-05-11
-$10.40M
derived: sum of 2 quarters · filed 2023-05-11
-$19.41M
derived: sum of 3 quarters · filed 2023-05-11
-$28.10M
derived: sum of 4 quarters · filed 2023-05-11
2021-12-31$3.24M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15
-$5.77M
derived: sum of 2 quarters · filed 2023-03-15
-$14.46M
derived: sum of 3 quarters · filed 2023-03-15
-$41.35M
10-K · filed 2023-03-15
2021-09-30-$9.01M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
-$17.70M
derived: sum of 2 quarters · filed 2022-11-14
-$44.59M
10-Q · filed 2022-11-14
-$43.14M
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30-$8.69M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
-$35.58M
10-Q · filed 2022-08-09
-$34.13M
derived: sum of 3 quarters · filed 2022-08-09
-$37.03M
derived: sum of 4 quarters · filed 2022-08-09
2021-03-31-$26.89M
10-Q · filed 2022-05-13
-$25.44M
derived: sum of 2 quarters · filed 2022-05-13
-$28.34M
derived: sum of 3 quarters · filed 2022-05-13
-$49.12M
derived: sum of 4 quarters · filed 2022-05-13
2020-12-31$1.45M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18
-$1.46M
derived: sum of 2 quarters · filed 2022-03-18
-$22.23M
derived: sum of 3 quarters · filed 2022-03-18
-$61.01M
10-K · filed 2022-03-18
2020-09-30-$2.90M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12
-$23.68M
derived: sum of 2 quarters · filed 2021-11-12
-$62.45M
10-Q · filed 2021-11-12
-$73.88M
derived: sum of 4 quarters · filed 2021-11-12
2020-06-30-$20.77M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12
-$59.55M
10-Q · filed 2021-08-12
-$70.98M
derived: sum of 3 quarters · filed 2021-08-12
-$95.33M
derived: sum of 4 quarters · filed 2021-08-12
2020-03-31-$38.78M
10-Q · filed 2021-05-12
-$50.21M
derived: sum of 2 quarters · filed 2021-05-12
-$74.56M
derived: sum of 3 quarters · filed 2021-05-12
-$89.45M
derived: sum of 4 quarters · filed 2021-05-12
2019-12-31-$11.43M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16
-$35.78M
derived: sum of 2 quarters · filed 2021-03-16
-$50.67M
derived: sum of 3 quarters · filed 2021-03-16
-$128.17M
10-K · filed 2021-03-16
2019-09-30-$24.35M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06
-$39.24M
derived: sum of 2 quarters · filed 2020-11-06
-$116.74M
10-Q · filed 2020-11-06
-$129.08M
derived: sum of 4 quarters · filed 2020-11-06
2019-06-30-$14.89M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07
-$92.39M
10-Q · filed 2020-08-07
-$104.72M
derived: sum of 3 quarters · filed 2020-08-07
-$26.55M
derived: sum of 4 quarters · filed 2020-08-07
2019-03-31-$77.50M
10-Q · filed 2020-05-08
-$89.83M
derived: sum of 2 quarters · filed 2020-05-08
-$11.66M
derived: sum of 3 quarters · filed 2020-05-08
$44.60M
derived: sum of 4 quarters · filed 2020-05-08
2018-12-31-$12.34M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28
$65.83M
derived: sum of 2 quarters · filed 2020-02-28
$122.09M
derived: sum of 3 quarters · filed 2020-02-28
$150.79M
10-K · filed 2020-02-28
2018-09-30$78.17M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07
$134.43M
derived: sum of 2 quarters · filed 2019-11-07
$163.13M
10-Q · filed 2019-11-07
$223.66M
derived: sum of 4 quarters · filed 2020-02-28
2018-06-30$56.26M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07
$84.96M
10-Q · filed 2019-08-07
$145.49M
derived: sum of 3 quarters · filed 2020-02-28
$197.25M
derived: sum of 4 quarters · filed 2020-02-28
2018-03-31$28.70M
10-Q · filed 2019-05-07
$89.23M
derived: sum of 2 quarters · filed 2020-02-28
$141.00M
derived: sum of 3 quarters · filed 2020-02-28
2017-12-31$60.53M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28
$112.30M
derived: sum of 2 quarters · filed 2020-02-28
$97.14M
10-K · filed 2020-02-28
2017-09-30$51.76M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06
$36.60M
10-Q · filed 2018-11-06
2017-06-30-$15.16M
10-Q · filed 2018-08-08
2016-12-31$29.65M
10-K · filed 2019-02-27
2011-12-31$32.97M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28
$75.73M
derived: sum of 2 quarters · filed 2012-02-28
$78.46M
derived: sum of 3 quarters · filed 2012-02-28
$66.34M
10-K · filed 2012-02-28
2011-09-30$42.76M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07
$45.49M
derived: sum of 2 quarters · filed 2011-11-07
$33.37M
10-Q · filed 2011-11-07
$34.95M
derived: sum of 4 quarters · filed 2012-02-28
2011-06-30$2.73M
derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-08
-$9.39M
10-Q · filed 2011-08-08
-$7.81M
derived: sum of 3 quarters · filed 2012-02-28
$21.44M
derived: sum of 4 quarters · filed 2012-02-28
2011-03-31-$12.12M
10-Q · filed 2011-05-09
-$10.53M
derived: sum of 2 quarters · filed 2012-02-28
$18.71M
derived: sum of 3 quarters · filed 2012-02-28
-$7.31M
derived: sum of 4 quarters · filed 2012-02-28
2010-12-31$1.59M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28
$30.83M
derived: sum of 2 quarters · filed 2012-02-28
$4.81M
derived: sum of 3 quarters · filed 2012-02-28
-$19.21M
10-K · filed 2012-02-28
-$19.22M
10-K · filed 2011-03-01
2010-09-30$29.25M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07
$3.22M
derived: sum of 2 quarters · filed 2011-11-07
-$20.80M
10-Q · filed 2011-11-07
-$20.80M
10-Q · filed 2010-11-09
-$33.72M
derived: sum of 4 quarters · filed 2012-02-28
2010-06-30-$26.02M
derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-08
-$50.05M
10-Q · filed 2011-08-08
-$50.05M
10-Q · filed 2010-08-09
-$62.96M
derived: sum of 3 quarters · filed 2012-02-28
$19.32M
derived: sum of 4 quarters · filed 2012-02-28
2010-03-31-$24.03M
10-Q · filed 2011-05-09
-$36.94M
derived: sum of 2 quarters · filed 2012-02-28
$45.35M
derived: sum of 3 quarters · filed 2012-02-28
2009-12-31-$12.92M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28
$69.37M
derived: sum of 2 quarters · filed 2012-02-28
$38.63M
10-K · filed 2012-02-28
$38.63M
10-K · filed 2011-03-01
2009-09-30$82.29M
derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-09
$51.55M
10-Q · filed 2010-11-09
2009-06-30-$30.74M
10-Q · filed 2010-08-09
2008-12-31-$49.16M
10-K · filed 2011-03-01